Universe Pharmaceuticals (UPC) Short-term Investments: 2021-2024
- Universe Pharmaceuticals' Short-term Investments rose 0.79% to $1.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.4 million, marking a year-over-year increase of 0.79%. This contributed to the annual value of $1.4 million for FY2024, which is 0.79% up from last year.
- According to the latest figures from Q3 2024, Universe Pharmaceuticals' Short-term Investments is $1.4 million, which was down 45.49% from $2.5 million recorded in Q1 2024.
- Universe Pharmaceuticals' 5-year Short-term Investments high stood at $14.3 million for Q1 2022, and its period low was $1.4 million during Q3 2023.
- Moreover, its 3-year median value for Short-term Investments was $7.8 million (2022), whereas its average is $7.7 million.
- Per our database at Business Quant, Universe Pharmaceuticals' Short-term Investments slumped by 89.60% in 2023 and then climbed by 0.79% in 2024.
- Over the past 4 years, Universe Pharmaceuticals' Short-term Investments (Quarterly) stood at $13.7 million in 2021, then decreased by 4.20% to $13.1 million in 2022, then slumped by 89.60% to $1.4 million in 2023, then grew by 0.79% to $1.4 million in 2024.
- Its Short-term Investments stands at $1.4 million for Q3 2024, versus $2.5 million for Q1 2024 and $1.4 million for Q3 2023.
